Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules
Completed · Phase 1
Conditions studied: Healthy
In brief
The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.
Key facts
- Study ID
- NCT00839293
- Run by
- Abbott
- People needed
- 32
- Starts
- 2009-02-01
- Last updated by the study team
- 2010-10-15
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- A condition of general good health
- BMI 18 to 29
You may not qualify if…
- Currently enrolled in another clinical study
- Females who are pregnant or breast-feeding
Where it is running
- Site Reference ID/Investigator# 16862 — Waukegan, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.